Plasmodium vivax AMA1: implications of distinct haplotypes for immune response

Bittencourt, N. C. et al. (2020) Plasmodium vivax AMA1: implications of distinct haplotypes for immune response. PLoS Neglected Tropical Diseases, 14(7), e0008471. (doi: 10.1371/journal.pntd.0008471) (PMID:32639964) (PMCID:PMC7371208)

[img] Text
252895.pdf - Published Version
Available under License Creative Commons Attribution.

2MB

Abstract

In Brazil, Plasmodium vivax infection accounts for around 80% of malaria cases. This infection has a substantial impact on the productivity of the local population as the course of the disease is usually prolonged and the development of acquired immunity in endemic areas takes several years. The recent emergence of drug-resistant strains has intensified research on alternative control methods such as vaccines. There is currently no effective available vaccine against malaria; however, numerous candidates have been studied in the past several years. One of the leading candidates is apical membrane antigen 1 (AMA1). This protein is involved in the invasion of Apicomplexa parasites into host cells, participating in the formation of a moving junction. Understanding how the genetic diversity of an antigen influences the immune response is highly important for vaccine development. In this study, we analyzed the diversity of AMA1 from Brazilian P. vivax isolates and 19 haplotypes of P. vivax were found. Among those sequences, 33 nonsynonymous PvAMA1 amino acid sites were identified, whereas 20 of these sites were determined to be located in predicted B-cell epitopes. Nonsynonymous mutations were evaluated for their influence on the immune recognition of these antigens. Two distinct haplotypes, 5 and 16, were expressed and evaluated for reactivity in individuals from northern Brazil. Both PvAMA1 variants were reactive. Moreover, the IgG antibody response to these two PvAMA1 variants was analyzed in an exposed but noninfected population from a P. vivax endemic area. Interestingly, over 40% of this population had antibodies recognizing both variants. These results have implications for the design of a vaccine based on a polymorphic antigen.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Da Silva Filho, Dr Joao
Creator Roles:
Silva-Filho, J. L.Formal analysis, Writing – review and editing
Authors: Bittencourt, N. C., Silva, A. B. I. E. d., Virgili, N. S., Schappo, A. P., Gervásio, J. H. D. B., Pimenta, T. S., Kujbida Junior, M. A., Ventura, A. M. R. S., Libonati, R. M. F., Silva-Filho, J. L., dos Santos, H. G., Lopes, S. C. P., Lacerda, M. V. G., Machado, R. L. D., Costa, F. T. M., and Albrecht, L.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:PLoS Neglected Tropical Diseases
Publisher:Public Library of Science
ISSN:1935-2727
ISSN (Online):1935-2735
Published Online:08 July 2020
Copyright Holders:Copyright © 2020 Bittencourt et al.
First Published:First published in PLoS Neglected Tropical Diseases 14(7): e0008471
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record